Cover Image
市場調查報告書

全球體外診斷市場(臨床化學、免疫疾病審定、糖尿病檢驗、血液檢驗、分子診斷):產業分析、規模、市場佔有率、成長率與預測

In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018

出版商 Transparency Market Research 商品編碼 277693
出版日期 內容資訊 英文 124 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球體外診斷市場(臨床化學、免疫疾病審定、糖尿病檢驗、血液檢驗、分子診斷):產業分析、規模、市場佔有率、成長率與預測 In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018
出版日期: 2013年07月31日 內容資訊: 英文 124 Pages
簡介

本報告提供全球的各種的體外診斷(IDV)市場相關分析,整體市場結構和促進、阻礙因素,及各產品、不同用途、各地區及主要國家(美國、中國、印度)的詳細的市場規模趨勢(過去3年的實際成果值和今後6年的預測值)、競爭環境,再加上主要企業簡介(企業與財務概要、產業策略、產品結構、近幾年趨勢)等調查,並將結果概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場概要

  • 市場趨勢與未來展望
    • 全球體外診斷市場(總計9年份)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
    • 波特的五力分析
  • 市場誘因分析:各地區

第4章 各產品市場(品質的資訊)

  • 概要
  • 臨床化學
  • 免疫疾病審定
  • 糖尿病檢驗
  • 血液檢驗
  • 分子診斷
  • 其他

第5章 各地區市場(總計9年份)

  • 概要
  • 北美市場
  • 歐洲市場
  • 亞太地區市場
  • 其他的地區的市場

第6章 美國市場:各產品(總計9年份)

  • 概要
  • 臨床化學用體外診斷
  • 免疫疾病審定用體外診斷
  • 糖尿病檢驗用體外診斷
  • 血液檢驗用體外診斷
  • 分子診斷用體外診斷
  • 其他體外診斷

第7章 中國市場:各產品(總計9年份)

  • 概要
  • 臨床化學用體外診斷
  • 免疫疾病審定用體外診斷
  • 糖尿病檢驗用體外診斷
  • 血液檢驗用體外診斷
  • 分子診斷用體外診斷
  • 其他體外診斷

第8章 印度市場:各產品(總計9年份)

  • 概要
  • 臨床化學用體外診斷
  • 免疫疾病審定用體外診斷
  • 糖尿病檢驗用體外診斷
  • 血液檢驗用體外診斷
  • 分子診斷用體外診斷
  • 其他體外診斷

第9章 競爭環境

  • 主要企業的市場佔有率

第10章 企業簡介

  • Abbott Laboratories Inc.
  • Alere, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Beckman Coulter, Inc.
  • Gen-Probe Incorporated
  • Johnson and Johnson
  • Life Technologies Corporation
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.

圖表一覽

目錄

In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 - 2018, keeping 2011 as the base year.

The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.

The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.

This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.

The global in vitro diagnostics market is categorized into the following segments:

  • Market by Products
    • U.S.
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
    • India
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
    • China
      • Clinical Chemistry
      • Immunoassay
      • Diabetes Testing
      • Blood Testing
      • Molecular Diagnostics
      • Others (Flow Cytometry, Microbiological Diagnostic Techniques)
  • Market by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Research Methodology
  • 1.3. Market Segmentation

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Market Trend and Future Outlook
    • 3.1.1 Global In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • 3.2. Market Dynamics
    • 3.2.1. Market drivers
      • 3.2.1.1. Rising Number of Patients with Infectious and Chronic Diseases
      • 3.2.1.2. Increasing Global Healthcare Expenditure
      • 3.2.1.3. Demand for Rapid and Minimally- or Non-Invasive Diagnostic Tools & Techniques
      • 3.2.1.4. Impact Analysis of the Market Drivers
    • 3.2.2. Market Restraints
      • 3.2.2.1. Reimbursement Challenges Retards the Growth of Market
      • 3.2.2.2. Uncertain and Ambiguous Regulatory environment restrains In Vitro Diagnostics market
      • 3.2.2.3. Impact Analysis of the Market Restraints
    • 3.2.3. Market Opportunities
      • 3.2.3.1. Molecular Diagnostics: Key to Future
      • 3.2.3.2. Epigenomics-Based Diagnostics expected to be an Emerging segment in In-Vitro Diagnostic Market
    • 3.2.4. Porter's Five Forces Analysis for In Vitro Diagnostic Market
      • 3.2.4.1. Bargaining Power of Suppliers
      • 3.2.4.2. Bargaining Power of Buyers
      • 3.2.4.3. Threat of new entrants
      • 3.2.4.4. Threat of substitutes
    • 3.2.5. Competitive rivalry
  • 3.3. Market Attractiveness Analysis of the Global In-Vitro Diagnostics Market, by Geography

Chapter 4 - Global In Vitro Diagnostics Market, by Products (Qualitative information)

  • 4.1. Overview
  • 4.2. Clinical Chemistry
  • 4.3. Immunoassay
  • 4.4. Diabetes Testing
  • 4.5. Blood Testing
  • 4.6. Molecular Diagnosis
  • 4.7. Others

Chapter 5 - Global In Vitro Diagnostics Market, by Geography

  • 5.1. Overview
  • 5.2. North America
    • 5.2.1. North America In Vitro Diagnostics Market, 2010-2018 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe In Vitro Diagnostics Market, 2010-2018 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific In Vitro Diagnostics Market, 2010-2018 (USD Million)
  • 5.5. Rest of the World
    • 5.5.1. ROW In Vitro Diagnostics Market, 2010-2018 USD Million)

Chapter 6 - U.S. In Vitro Diagnostics Market, by Products

  • 6.1. Overview
  • 6.2. Clinical Chemistry IVD Market, 2010 - 2018 (USD Million)
  • 6.3. Immunoassay IVD Market, 2010 - 2018 (USD Million)
  • 6.4. Diabetes Testing IVD Market, 2010 - 2018 (USD Million)
  • 6.5. Blood Testing IVD Market, 2010 - 2018 (USD Million)
  • 6.6. Molecular Diagnosis IVD Market, 2010 - 2018 (USD Million)
  • 6.7. Others IVD Market, 2010 - 2018 (USD Million)

Chapter 7 - China In Vitro Diagnostics Market, by Products

  • 7.1. Overview
  • 7.2. Clinical Chemistry IVD Market, 2010 - 2018 (USD Million)
  • 7.3. Immunoassay IVD Market, 2010 - 2018 (USD Million)
  • 7.4. Diabetes Testing IVD Market, 2010 - 2018 (USD Million)
  • 7.5. Blood Testing IVD Market, 2010 - 2018 (USD Million)
  • 7.6. Molecular Diagnosis IVD Market, 2010 - 2018 (USD Million)
  • 7.7. Others IVD Market, 2010 - 2018 (USD Million)

Chapter 8 - India In Vitro Diagnostics Market, by Products

  • 8.1. Overview
  • 8.2. Clinical Chemistry IVD Market, 2010 - 2018 (USD Million)
  • 8.3. Immunoassay IVD Market, 2010 - 2018 (USD Million)
  • 8.4. Diabetes Testing IVD Market, 2010 - 2018 (USD Million)
  • 8.5. Blood Testing IVD Market, 2010 - 2018 (USD Million)
  • 8.6. Molecular Diagnosis IVD Market, 2010 - 2018 (USD Million)
  • 8.7. Others IVD Market, 2010 - 2018 (USD Million)

Chapter 9 - Competitive Landscape

  • 9.1. Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)

Chapter 10 - Company Profiles

  • 10.1. Abbott Laboratories Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial overview
    • 10.1.3. Business Strategies
    • 10.1.4. Product Portfolio
    • 10.1.5. Recent Developments
  • 10.2. Alere, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Overview
    • 10.2.3. Business Strategies
    • 10.2.4. Product Portfolio
    • 10.2.5. Recent Developments
  • 10.3. Bayer AG
    • 10.3.1. Company Overview
    • 10.3.2. Financial Overview
    • 10.3.3. Business Strategies
    • 10.3.4. Product Portfolio
    • 10.3.5. Recent Developments
  • 10.4. Becton, Dickinson and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Overview
    • 10.4.3. Business Strategies
    • 10.4.4. Product Portfolio
    • 10.4.5. Recent Developments
  • 10.5. Biomerieux SA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Overview
    • 10.5.3. Business Strategies
    • 10.5.4. Product Portfolio
    • 10.5.5. Recent Developments
  • 10.6. Beckman Coulter, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial overview
    • 10.6.3. Business Strategies
    • 10.6.4. Product portfolio
    • 10.6.5. Recent developments
  • 10.7. Gen-Probe Incorporated
    • 10.7.1. Company Overview
    • 10.7.2. Financial Overview
    • 10.7.3. Business Strategies
    • 10.7.4. Product Portfolio
    • 10.7.5. Recent Developments
  • 10.8. Johnson and Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Overview
    • 10.8.3. Business Strategies
    • 10.8.4. Product Portfolio
    • 10.8.5. Recent Developments
  • 10.9. Life Technologies Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Overview
    • 10.9.3. Business Strategies
    • 10.9.4. Product Portfolio
    • 10.9.5. Recent Developments
  • 10.10. F. Hoffmann-La Roche Ltd
    • 10.10.1. Company Overview
    • 10.10.2. Financial Overview
    • 10.10.3. Business strategies
    • 10.10.4. Product portfolio
    • 10.10.5. Recent developments
  • 10.11. Siemens Healthcare
    • 10.11.1. Company Overview
    • 10.11.2. Financial Overview
    • 10.11.3. Business Strategies
    • 10.11.4. Product Portfolio
    • 10.11.5. Recent Developments
  • 10.12. Thermo Fisher Scientific, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial overview
    • 10.12.3. Business strategies
    • 10.12.4. Product portfolio
    • 10.12.5. Recent developments

List of Figures

  • FIG. 1: Market Segmentation for the In Vitro Diagnostics Market
  • FIG. 2: Global In Vitro Diagnostics Market, U.S., 2011 (USD Million)
  • FIG. 3: Global In Vitro Diagnostics Market, China., 2011 (USD Million)
  • FIG. 4: Global In Vitro Diagnostics Market, India, 2011 (USD Million)
  • FIG. 5: Global In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • FIG. 6: Total Healthcare Expenditure, Per Capita ( in USD)
  • FIG. 7: Porter's Five Forces Analysis for In Vitro Diagnostic Market
  • FIG. 8: Market Attractiveness Analysis of the Microscopy Devices Market, by geography
  • FIG. 9: Comparative Analysis of the Global IVD Market, by Geography, 2011 & 2018 (%)
  • FIG. 10: N. America In Vitro Diagnostics Market , 2010 - 2018 (USD Million)
  • FIG. 11: Europe In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • FIG. 12: Asia Pacific In Vitro Diagnostics Market, 2010 - 2018 (USD Million)
  • FIG. 13: RoW In Vitro Diagnostics Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 14: Comparative Analysis of the U.S. In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
  • FIG. 15: Clinical Chemistry IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 16: Immunoassay IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 17: Diabetes IVD Market, U.S., Market, 2010 - 2018 (USD Million)
  • FIG. 18: Blood Testing IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 19: Molecular Diagnosis IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 20: Other IVD Market, U.S., 2010 - 2018 (USD Million)
  • FIG. 21: Comparative Analysis of the China In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
  • FIG. 22: Clinical Chemistry IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 23: Immunoassay IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 24: Diabetes IVD Market, China, Market, 2010 - 2018 (USD Million)
  • FIG. 25: Blood Testing IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 26: Molecular Diagnosis IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 27: Other IVD Market, China, 2010 - 2018 (USD Million)
  • FIG. 28: Comparative Analysis of the Indian In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
  • FIG. 29: Clinical Chemistry IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 30: Immunoassay IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 31: Diabetes testing IVD Market, India, Market, 2010 - 2018 (USD Million)
  • FIG. 32: Blood Testing IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 33: Molecular Diagnosis IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 34: Other IVD Market, India, 2010 - 2018 (USD Million)
  • FIG. 35: Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)
  • FIG. 36: Annual Revenue of Abbott Laboratories Inc., Diagnostics Division, 2010 - 2012 (USD million)
  • FIG. 37: Annual Revenue of Alere Inc., 2009- 2011 (USD million)
  • FIG. 38: Annual Sales of Bayer Healthcare, a division of Bayer AG, 2010-2012 (USD million)
  • FIG. 39: Annual revenue of BD Company, 2010 - 2012 (USD million)
  • FIG. 40: Annual revenue of BioMerieux SA, 2010 - 2012 (USD million)
  • FIG. 41: Annual revenue of Beckman Coulter, Inc., 2009 - 2010 (USD million)
  • FIG. 42: Annual revenue of Gen-Probe, Inc., 2010 - 2012 (USD Million)
  • FIG. 43: Annual revenue of Johnson and Johnson, Medical Devices an d Diagnostics Segment , 2010 - 2012 (USD Million)
  • FIG. 44: Annual revenue of Life Technologies Corporation, 2010 - 2012 (USD Million)
  • FIG. 45: Annual revenue of Roche Diagnostics, division of Roche Holdings, 2010 - 2012 (USD Million)
  • FIG. 46: Annual Revenue of Siemens Healthcare, 2009-2011 (USD million)
  • FIG. 47: (Conversion rate: 1 Euro = 1.33 USD)
  • FIG. 48: Annual revenue of Thermo Fisher Scientific, Inc., 2010 - 2012 (USD million)

List of Tables

  • TABLE 1: Market Snapshot: Global In Vitro Diagnostics Market
  • TABLE 2: Impact Analysis of the Market Drivers for In-Vitro Diagnostics Market
  • TABLE 3: Impact Analysis of the Market Restraints for Stem Cells Market
  • TABLE 4: Global IVD Market, by Geography, 2010 - 2018 (USD Million)
  • TABLE 5: U.S. IVD Market, by Products, 2010 - 2018 (USD Million)
  • TABLE 6: China IVD Market, by Products, 2010 - 2018 (USD Million)
  • TABLE 7: Indian IVD Market, by Products, 2010 - 2018 (USD Million)
Back to Top